
A buoyant stock market, cheaper pump prices, and the housing revival are trumping the worrisome negatives

Cheaper Asian imports and economic disaster in Europe has made U.S. manufacturing soft

Sounds like Watergate was a lot of fun. No wonder Washington's old hands can't help but reminisce

Almost 80 percent of the U.S. military's mobile devices are BlackBerry products, but now that will probably change

A government crackdown on foreign investment has sent speculators fleeing, but one man is more bullish than ever

Quit-smoking apps get hot in a $1 billion market

On a new reality TV show, first prize is a fast-food outlet. Winners, beware

For some, Joel Peterson says, online courses or specialized one-year programs may be better choices than the MBA

Bitcoin crashed last month. That hasn't stopped venture capital firms from investing in Bitcoin companies
Pharmajet.com
Kathy Callender, 67
Golden, Colo.
After 12 years in business, PharmaJet may finally be able to sell its first product: a simple, needle-free injection device with a disposable syringe designed for use in third-world countries that can help prevent injury and the spread of disease. The company just received clearance from the Food & Drug Administration to use the tool for vaccines and injectable medicines. The 25-person company has not recorded any revenues to date, but plans to start selling its devices this year. So far, it has been developing the product with help from angel investors. "I want to make a difference in global world health," says Callender, a 35-year veteran of the health-care industry. "Before starting the firm, my husband and I would do medical mission work in the developing world, and it really just showed us how much need there is out there. I want to get needles out of the garbage and prevent injury to workers and patients."